EC approves Gentium's defibrotide

The European Commission approved an MAA from Gentium S.p.A. (NASDAQ:GENT) for Defitelio defibrotide to treat severe hepatic veno-occlusive disease (VOD) in adults and children undergoing hematopoietic...